Potential Utility of Radiopharmaceuticals in the Battle Against SARSCov- 2 and COVID-19 Pandemic.

Sager, Omer; Dincoglan, Ferrat; Demiral, Selcuk; Beyzadeoglu, Murat

Sager, Omer; Dincoglan, Ferrat; Demiral, Selcuk; Beyzadeoglu, Murat.

Afiliación

Sager O; Department of Radiation Oncology, Gulhane Faculty of Medicine, University of Health Sciences Turkey, Ankara, Turkey.
Dincoglan F; Department of Radiation Oncology, Gulhane Faculty of Medicine, University of Health Sciences Turkey, Ankara, Turkey.
Demiral S; Department of Radiation Oncology, Gulhane Faculty of Medicine, University of Health Sciences Turkey, Ankara, Turkey.
Beyzadeoglu M; Department of Radiation Oncology, Gulhane Faculty of Medicine, University of Health Sciences Turkey, Ankara, Turkey.

Curr Radiopharm ; 15(2): 93-95, 2022.

Article en En | MEDLINE | ID: mdl-34635047

Asunto(s)

COVID-19; Pandemias; Antivirales/farmacología; Antivirales/uso terapéutico; Humanos; Radiofármacos/farmacología; Radiofármacos/uso terapéutico; SARS-CoV-2

Palabras clave

COVID-19; Radiopharmaceutical; SARS-CoV-2; coronavirus; pandemic; targeted radiotherapy

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Pandemias / COVID-19 Límite: Humans Idioma: En Revista: Curr Radiopharm Año: 2022 Tipo del documento: Article País de afiliación: Turquía Pais de publicación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google